Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,361 | 151 | 99.8% |
| Education | $10.28 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,374 | 29 | $0 (2024) |
| Lilly USA, LLC | $983.09 | 50 | $0 (2024) |
| Novo Nordisk Inc | $503.18 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $386.49 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $373.06 | 23 | $0 (2023) |
| Amgen Inc. | $315.77 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $139.71 | 3 | $0 (2023) |
| Amarin Pharma Inc. | $120.99 | 2 | $0 (2018) |
| PFIZER INC. | $95.54 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $43.33 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $217.04 | 7 | AstraZeneca Pharmaceuticals LP ($121.84) |
| 2023 | $553.75 | 21 | Lilly USA, LLC ($217.55) |
| 2022 | $565.27 | 24 | Novo Nordisk Inc ($160.95) |
| 2021 | $91.70 | 7 | Merck Sharp & Dohme Corporation ($38.10) |
| 2020 | $85.47 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($36.61) |
| 2019 | $473.55 | 12 | AstraZeneca Pharmaceuticals LP ($267.19) |
| 2018 | $1,214 | 37 | AstraZeneca Pharmaceuticals LP ($377.11) |
| 2017 | $1,171 | 39 | AstraZeneca Pharmaceuticals LP ($483.13) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), TRADJENTA, JARDIANCE | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: DIABETES | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: DIABETES | ||||||
| 05/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: PAIN | ||||||
| 05/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY, GLYXAMBI | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: DIABETES | ||||||
| 04/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: PAIN | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Respiratory | ||||||
| 12/01/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: PAIN | ||||||
| 10/02/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: PAIN | ||||||
| 09/28/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $113.40 | General |
| 09/25/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Diabetes | ||||||
| 09/19/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $101.13 | General |
| Category: Diabetes | ||||||
| 08/15/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Diabetes | ||||||
| 06/28/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: VACCINES | ||||||
| 06/14/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Neuroscience | ||||||
| 06/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: DIABETES | ||||||
| 05/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: DIABETES | ||||||
| 05/03/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $68.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/26/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes | ||||||
| 04/19/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Diabetes | ||||||
| 04/10/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: VACCINES | ||||||
| 03/28/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Neuroscience | ||||||
| 03/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: DIABETES | ||||||
| 02/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 110 | 325 | $73,070 | $25,454 |
| 2022 | 2 | 130 | 425 | $96,350 | $36,717 |
| 2021 | 1 | 134 | 468 | $107,640 | $41,155 |
| 2020 | 3 | 196 | 558 | $123,025 | $38,431 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 301 | $69,230 | $24,115 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 24 | $3,840 | $1,339 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 114 | 405 | $93,150 | $35,472 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 20 | $3,200 | $1,245 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 134 | 468 | $107,640 | $41,155 | 38.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 146 | 503 | $115,690 | $36,120 | 31.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 30 | 33 | $3,815 | $1,164 | 30.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 22 | $3,520 | $1,147 | 32.6% |
About Dr. Khin Tun, MD
Dr. Khin Tun, MD is a Internal Medicine healthcare provider based in Towson, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730167503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khin Tun, MD has received a total of $4,372 in payments from pharmaceutical and medical device companies, with $217.04 received in 2024. These payments were reported across 152 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($4,361).
As a Medicare-enrolled provider, Tun has provided services to 570 Medicare beneficiaries, totaling 1,776 services with total Medicare billing of $141,757. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Towson, MD
- Active Since 01/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730167503
Products in Payments
- TRULICITY (Drug) $658.30
- FARXIGA (Drug) $555.46
- TRADJENTA (Drug) $287.54
- Ozempic (Drug) $278.70
- FASENRA (Drug) $250.01
- BEVESPI AEROSPHERE (Drug) $248.67
- Aimovig (Biological) $213.77
- JARDIANCE (Drug) $189.69
- Victoza (Drug) $159.16
- MOUNJARO (Drug) $129.28
- BREZTRI (Drug) $124.58
- AIRSUPRA (Drug) $121.84
- Vascepa (Drug) $120.99
- STEGLATRO (Drug) $106.12
- Prolia (Biological) $102.00
- NURTEC ODT (Drug) $83.09
- SYMBICORT (Drug) $73.29
- VERQUVO (Drug) $68.69
- EMGALITY (Drug) $68.45
- BELSOMRA (Drug) $64.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Towson
Vikas Kalra, Md, MD
Internal Medicine — Payments: $20,342
Dr. Syed Zaidi, M.d, M.D
Internal Medicine — Payments: $20,308
Dr. David Edwards, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $14,404
Albert Deloskey, M.d, M.D
Internal Medicine — Payments: $14,028
Latrica Cook, M.d, M.D
Internal Medicine — Payments: $8,868
Madhat Arnouk, M.d, M.D
Internal Medicine — Payments: $8,212